Dregeoside A11
Dregeoside A11 is a natural product from Dregea volubilis.
Inquire / Order:
manager@chemfaces.com
Technical Inquiries:
service@chemfaces.com
Tel:
+86-27-84237783
Fax:
+86-27-84254680
Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to
24 months(2-8C).
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com
The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
Processes2021, 9(1), 153;
Life (Basel).2021, 11(7):616.
Front Pharmacol.2022, 13:906763.
Phytomedicine.2022, 100:154085.
Chem Biol Interact.2024, 394:110995.
Int J Mol Sci.2022, 23(24):16000.
J AOAC Int.2021, 104(6):1634-1651.
Molecules.2020, 25(7):1625.
Vietnam Journal of Food Control.2022, 5(2): 115-128.
Phytomedicine.2022, 99:153997.
Related and Featured Products
Chemical & Pharmaceutical Bulletin, 1983 , 31 (11) :3971-83.
Studies on the constituents of Asclepiadaceae plants. LVI. Isolation of new antitumor-active glycosides from Dregea volubilis (L.) BENTH.[Reference:
WebLink]
Seven new glycosides were isolated from the stem of Dregea volubilis (L.) BENTH.
METHODS AND RESULTS:
The structures of dregeoside Ap1 (1), dregeoside Ao1 (2), dregeoside Aa1 (3), Dregeoside A11 (4), dregeoside C11 (5), dregeoside Ka1 (6), and dregeoside Ka1 (7) were deduced on the basis of chemical and spectral evidence as drevogenin A 3-O-3-O-methyl-6-deoxy-β-D-allopyranosyl-(1→4)-β-D-oleandropyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside, drevogenin A 3-O-β-D-glucopyranosyl-(1→4)-3-O-methyl-6-deoxy-β-D-allopyranosyl-(1→4)-β-D-oleandropyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside, drevogenin A 3-O-3-O-methyl-6-deoxy-β-D-allopyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside, drevogenin A 3-O-β-D-glucopyranosyl-(1→4)-3-O-methyl-6-deoxy-β-D-allopyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside, drevogenin C 3-O-β-D-glucopyranosyl-(1→4)-3-O-methyl-6-deoxy-β-D-allopyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside, drebyssogenin K2 3-O-3-O-methyl-6-deoxy-β-D-allopyranosyl-(1→4)-β-D-oleandropyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside, and drebyssogenin K2 3-O-3-O-methyl-6-deoxy-β-D-allopyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside, respectively.
CONCLUSIONS:
Among them, 1 and 2 were active against Ehrlich carcinoma (solid type), and the latter was also active against melanoma B-16.
